Target intelligence / Profile preview

Eosinophil granule ontogeny transcript (EGOT)

Target
EGOT
Molecular classification
Long non-coding RNA (lncRNA), Non-protein coding RNA, Antisense totally intronic transcript (TIN)
01

Overview

Eosinophil granule ontogeny transcript (EGOT) is a long non-coding RNA (lncRNA) gene located antisense within an intron of the ITPR1 gene. It is most highly expressed during early eosinophil development, where it regulates the transcript levels of major basic protein (MBP) and eosinophil-derived neurotoxin (EDN), proteins essential to eosinophil function[5][3]. EGOT has been experimentally shown not to associate with ribosomes and functions as a regulatory RNA, possibly via forming RNA-protein complexes or acting as a natural siRNA[3][5]. Beyond hematopoietic differentiation, EGOT acts as a suppressor in glioma: overexpression inhibits glioma cell proliferation and migration and induces apoptosis[1]. In renal tubular cells, decreased EGOT promotes autophagy during hypoxic stress, with EGOT regulated post-transcriptionally by the RNA-binding protein HuR[2]. Thus, EGOT is a regulatory lncRNA implicated in cancer biology, autophagy, and immune cell differentiation, but it is not considered a classical therapeutic target such as a receptor, enzyme, or transporter.

Other names
EGONCRNA00190eosinophil granule ontogenynon-protein coding RNA 190EGO-BEGO-A
02

Mechanism of action

Acts as a transcriptional regulator for granule protein genes (such as major basic protein [MBP] and eosinophil-derived neurotoxin [EDN]); May function as a natural siRNA or RNA-protein complex; Interacts with RNA-binding protein HuR to modulate autophagy-related gene expression

03

Biological functions

Regulation of eosinophil granule protein expressionRegulation of cell proliferationRegulation of cell migrationInduction of apoptosisRegulation of autophagyTranscriptional regulation
04

Disease associations

Cancer, particularly gliomaInflammation (via roles in eosinophil biology)Potential roles in kidney injury and other diseases where autophagy or eosinophil function is involved
05

Biomarkers

Potential biomarker for glioma prognosis (reduced EGOT associated with more aggressive gliomas)Possible marker of eosinophil differentiation or activation

Beyond the preview

Go deeper on Eosinophil granule ontogeny transcript (EGOT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eosinophil granule ontogeny transcript (EGOT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call